Aggregating multiple test results to improve medical decision-making.

Aggregating multiple test results to improve medical decision-making.

Publication date: Jan 07, 2025

Gathering observational data for medical decision-making often involves uncertainties arising from both type I (false positive) and type II (false negative) errors. In this work, we develop a statistical model to study how medical decision-making can be improved by aggregating results from repeated diagnostic and screening tests. Our approach is relevant to not only clinical settings such as medical imaging, but also to public health, as highlighted by the need for rapid, cost-effective testing methods during the SARS-CoV-2 pandemic. Our model enables the development of testing protocols with an arbitrary number of tests, which can be customized to meet requirements for type I and type II errors. This allows us to adjust sensitivity and specificity according to application-specific needs. Additionally, we derive generalized Rogan-Gladen estimates of disease prevalence that account for an arbitrary number of tests with potentially different type I and type II errors. We also provide the corresponding uncertainty quantification.

Open Access PDF

Concepts Keywords
Diagnostic Aggregating
Pandemic Arbitrary
Protocols Decision
Rogan Errors
Statistical False
Gathering
Improve
Involves
Making
Multiple
Observational
Test
Testing
Tests
Uncertainties

Semantics

Type Source Name
disease MESH uncertainty
drug DRUGBANK Dimercaprol
disease IDO history
disease IDO process
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH COVID 19
disease IDO nucleic acid
pathway REACTOME Adaptive Immune System
disease MESH infection
disease IDO immune response
disease MESH tic
disease IDO algorithm
disease IDO protein
disease IDO symptom
disease MESH viral infections
disease MESH influenza
drug DRUGBANK Piroxicam
disease IDO assay
drug DRUGBANK Aspartame
disease IDO disposition
drug DRUGBANK Saquinavir
drug DRUGBANK Esomeprazole
disease MESH death
disease MESH morbidities
drug DRUGBANK Cysteamine
disease MESH complications
disease MESH impaired glucose tolerance
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Trihexyphenidyl
disease IDO blood
disease MESH viral load
drug DRUGBANK Morpholinylmercaptobenzothiazole
disease MESH asymptomatic infection
disease IDO immunodeficiency
drug DRUGBANK Diethylstilbestrol

Original Article

(Visited 1 times, 1 visits today)